SMTL ID : 4w5c.1 (4 other biounits)

Crystal structure analysis of cruzain with three Fragments: 1 (N-(1H-benzimidazol-2-yl)-1,3-dimethyl-pyrazole-4-carboxamide), 6 (2-amino-4,6-difluorobenzothiazole) and 9 (N-(1H-benzimidazol-2-yl)-3-(4-fluorophenyl)-1H-pyrazole-4-carboxamide).

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.27 Å

Oligo State

monomer

Ligands

1 x 3H5: N-(1H-benzimidazol-2-yl)-1,3-dimethyl-1H-pyrazole-4-carboxamide(Non-covalent)

3H5.1: 6 residues within 4Å: Chain A: Q.20, G.21, Q.22, C.23, M.146, W.189 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Q.22 pi-Stacking: A:W.185, A:W.185

1 x 3H6: N-(1H-benzimidazol-2-yl)-3-(4-fluorophenyl)-1H-pyrazole-4-carboxamide(Non-covalent)

3H6.2: 10 residues within 4Å: Chain A: G.24, S.26, S.65, G.66, G.67, L.68, M.69, A.139, L.161, D.162 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.26, A:G.67

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tochowicz, A. et al., Applying Fragments Based- Drug Design to identify multiple binding modes on cysteine protease. To Be Published

Release Date

2015-04-08

Peptides

Cruzipain: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cruzipain

Related Entries With Identical Sequence